What’s holding up the Shire-Baxalta deal? One word: Taxes

Carly Helfand

Shire and Baxalta both reportedly want to make a tie-up happen. So what's taking so long? According to the Financial Times, the potential now hinges on Shire's ability to put cash in the mix without triggering a hefty tax bill. And the Dublin drugmaker won't be proceeding until it's "highly confident" in the advice it receives, the newspaper's sources say.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS